Literature DB >> 6877305

Extrapyramidal reactions with high-dose metoclopramide.

M G Kris, L B Tyson, R J Gralla, R A Clark, J C Allen, L K Reilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6877305     DOI： 10.1056/nejm198308183090718

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.

Authors:  G F Fleming; E E Vokes; J M McEvilly; L Janisch; D Francher; L Smaldone
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Authors:  G L Plosker; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

4.  Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.

Authors:  E H Tan; P T Ang; K S Khoo
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

5.  A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.

Authors:  M Soukop
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

Review 6.  Antiemetics in cancer chemotherapy: historical perspective and current state of the art.

Authors:  M Tonato; F Roila; A Del Favero; E Ballatori
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

Review 7.  Methodology of antiemetic trials.

Authors:  J G McVie; K M de Bruijn
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 8.  Tropisetron. A review of the clinical experience.

Authors:  K M de Bruijn
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony Markham; Eugene M Sorkin
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

10.  Biotransformation of the antiemetic 5-HT3 antagonist tropisetron in liver and kidney slices of human, rat and dog with a comparison to in vivo.

Authors:  A E Vickers; V Fischer; M S Connors; W A Biggi; F Heitz; J P Baldeck; K Brendel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.